Condensed Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	$ 4,949,586	$ 7,236,238	$ (249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 388,519			388,519
Dividends declared and paid				(229,179)
Issuance of stock under stock plans and other (in shares)		488
Issuance of stock under stock plans and other		$ 82	19,838
Stock-based compensation expense			36,638
Other comprehensive income (loss)	$ 30,960				30,960
Common stock repurchased (in shares)		(1,079)
Common stock repurchased		$ (180)	(156,877)
Ending balance (in shares) at Jan. 30, 2021		368,894
Ending balance at Jan. 30, 2021		$ 61,484	4,849,185	7,395,578	(218,501)
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	4,949,586	7,236,238	(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(12,300)
Ending balance (in shares) at Oct. 30, 2021		525,331
Ending balance at Oct. 30, 2021	$ 37,992,542	$ 87,554	30,574,237	7,517,316	(186,565)
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	4,949,586	7,236,238	(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(14,400)
Ending balance (in shares) at Jan. 29, 2022		523,315
Ending balance at Jan. 29, 2022	$ 37,427,312	$ 87,221	30,093,961	7,434,748	(188,618)
Beginning balance (in shares) at Oct. 30, 2021		525,331
Beginning balance at Oct. 30, 2021	37,992,542	$ 87,554	30,574,237	7,517,316	(186,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	280,077			280,077
Dividends declared and paid				(362,645)
Issuance of stock under stock plans and other (in shares)		579
Issuance of stock under stock plans and other		$ 100	8,371
Stock-based compensation expense			86,939
Other comprehensive income (loss)	$ (2,053)				(2,053)
Common stock repurchased (in shares)	(2,100)	(2,595)
Common stock repurchased		$ (433)	(575,586)
Ending balance (in shares) at Jan. 29, 2022		523,315
Ending balance at Jan. 29, 2022	$ 37,427,312	$ 87,221	$ 30,093,961	$ 7,434,748	$ (188,618)